The Immediate Effect of Mobilisation With Movement in Amateur Futsal Athletes With Chronic Ankle Instability

March 8, 2021 updated by: Alexandre Portela, Escola Superior de Tecnologia da Saúde do Porto

The Immediate Effect of Two Mobilization With Movement Techniques on Dorsiflexion, Dynamic Balance and Performance Variables, in Futsal Athletes With Chronic Ankle Instability: A Randomized Controlled Trial

Chronic ankle instability (CAI) is an increasingly prevalent condition among futsal athletes. Mobilization with Movement (MWM) is a conservative rehabilitation strategy commonly used in this condition. Even so, the effects of two MWM dorsiflexion techniques on sports performance are not known. The aim is to analyze the immediate effect of two MWM techniques on the dorsiflexion range of motion, the dynamic balance and the performance variables in futsal athletes with CAI. Also, to analyze the impact of performing them in a different order.

Study Overview

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Porto, Portugal, 4200-072
        • Escola Superior de Saúde do Porto

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  1. A history of at least one significative ankle sprain:

    • Initial sprain must have occurred at least 12 months prior to study enrolment;
    • Was associated with inflammatory symptoms;
    • Created at least one interrupted day of desired physical activity;
    • The most recent injury must have occurred more than 3 months prior to study enrolment.
  2. A history of the previously injured ankle joint "giving way" and/or recurrent sprain and/or "feelings of instability":

    • Participants should report at least two episodes of "giving way" in the 12 months prior to study enrolment, to account for the seasonal nature of futsal;
    • Recurrent sprain was defined as two or more sprains to the same ankle.
  3. Self-reported ankle instability should be confirmed with the Ankle Instability Instrument: answer "yes" to at least 5 yes/no questions.

Exclusion Criteria:

  1. A history of previous surgeries to the musculoskeletal structures (i.e., bones, joint structures, nerves) in either lower extremity.
  2. A history of bilateral ankle sprain.
  3. A history of a fracture in either lower extremity requiring realignment.
  4. Acute injury to musculoskeletal structures of other joints of the lower extremity in the previous 3 months that impacted joint integrity and function (i.e., sprains, fractures), resulting in at least one interrupted day of desired physical activity.
  5. Have conditions for which manual therapy is generally contraindicated (such as the presence of a tumour, fracture, rheumatoid arthritis, osteoporosis, prolonged history of steroid use, or severe vascular disease).
  6. Receiving concurrent physiotherapy treatment in the last 3 months.
  7. Inability to read Portuguese.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobilisation with Movement 1 (MWM1)
Participants received two ankle dorsiflexion MWM techniques, with glides applied at fibula and talus. Three sets of 10 repetitions of each techniques, were administrated.

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the talus were performed, followed by 3 sets of 10 repetitions of a glide applied to the fibula.

Other Names:
  • Mulligan
Experimental: Mobilisation with Movement 2 (MWM2)
Participants received two ankle dorsiflexion MWM techniques, with glides applied at talus and fibula (order of application inverted). Three sets of 10 repetitions of each techniques, were administrated.

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the fibula were performed, followed by 3 sets of 10 repetitions of a glide applied to the talus.

Other Names:
  • Mulligan
Placebo Comparator: Placebo
The Placebo group participants performed the same number of sets and repetitions of lean/lunge forward into dorsiflexion, without any glide application, in the same position
The Placebo group participants performed the same number of sets and repetitions (6 sets of 20 repetitions) of lean/lunge forward into dorsiflexion, without any glide application.
Experimental: Intervention
The experimental groups (MWM1 and MWM2), were later merged into a single Intervention group.

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the talus were performed, followed by 3 sets of 10 repetitions of a glide applied to the fibula.

Other Names:
  • Mulligan

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the fibula were performed, followed by 3 sets of 10 repetitions of a glide applied to the talus.

Other Names:
  • Mulligan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dorsiflexion range of motion
Time Frame: Immediate after procedure
The dorsiflexion range of motion (DFROM) of the ankle joint was measured by the Weight-Bearing Lunge Test (WBLT)
Immediate after procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic balance
Time Frame: Immediate after procedure
The dynamic balance was measured by the anterior (ANT), posteromedial (PM) and posterolateral (PL) reach directions of the Star Excursion Balance Test (SEBT)
Immediate after procedure
Performance variables
Time Frame: Immediate after procedure
The performance variables were measured by the time needed to complete the Side Hop Test and the Sprint Test
Immediate after procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 14, 2021

Primary Completion (Actual)

February 28, 2021

Study Completion (Actual)

February 28, 2021

Study Registration Dates

First Submitted

December 30, 2020

First Submitted That Met QC Criteria

January 6, 2021

First Posted (Actual)

January 7, 2021

Study Record Updates

Last Update Posted (Actual)

March 9, 2021

Last Update Submitted That Met QC Criteria

March 8, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ESS-MWM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Injuries and Disorders

Clinical Trials on Mobilisation With Movement 1

3
Subscribe